Corticosteroid‐induced gene expression in allergen‐challenged asthmatic subjects taking inhaled budesonide
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE Inhaled corticosteroids (ICS) are the cornerstone of asthma pharmacotherapy and, acting via the glucocorticoid receptor (GR), reduce inflammatory gene expression. While this is often attributed to a direct inhibitory effect of the GR on inflammatory gene transcription, corticosteroids also induce the expression of anti‐inflammatory genes in vitro. As there are no data to support this effect in asthmatic subjects taking ICS, we have assessed whether ICS induce anti‐inflammatory gene expression in subjects with atopic asthma. EXPERIMENTAL APPROACH Bronchial biopsies from allergen‐challenged atopic asthmatic subjects taking inhaled budesonide or placebo were subjected to gene expression analysis using real‐time reverse transcriptase‐PCR for the corticosteroid‐inducible genes (official gene symbols with aliases in parentheses): TSC22D3 [glucocorticoid‐induced leucine zipper (GILZ)], dual‐specificity phosphatase‐1 (MAPK phosphatase‐1), both anti‐inflammatory effectors, and FKBP5 [FK506‐binding protein 51 (FKBP51)], a regulator of GR function. Cultured pulmonary epithelial and smooth muscle cells were also treated with corticosteroids before gene expression analysis. KEY RESULTS Compared with placebo, GILZ and FKBP51 mRNA expression was significantly elevated in budesonide‐treated subjects. Budesonide also increased GILZ expression in human epithelial and smooth muscle cells in culture. Immunostaining of bronchial biopsies revealed GILZ expression in the airways epithelium and smooth muscle of asthmatic subjects. CONCLUSIONS AND IMPLICATIONS Expression of the corticosteroid‐induced genes, GILZ and FKBP51, is up‐regulated in the airways of allergen‐challenged asthmatic subjects taking inhaled budesonide. Consequently, the biological effects of corticosteroid‐induced genes should be considered when assessing the actions of ICS. Treatment modalities that increase or decrease GR‐dependent transcription may correspondingly affect corticosteroid efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Self-citationMechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060336 · Cited by 430 · cited 1×
“This point is confirmed by findings that animals (or cells) lacking MKP-1 reveal deficits in, although not a total lack of, the repressive effects of corticosteroids (Abraham et al., 2006; Furst et al., 2007; Maier et al., 2007).”
BackgroundA New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427 · cited 4×
“, 2007), are consistent with antiinflammatory efficacy (Ayroldi and Riccardi, 2009), FKBP51 function is less well defined and may involve negative regulation of GR activity (Davies et al., 2002; Stechschulte and Sanchez, 2011).”
BackgroundInfluentialProud, D., Sanders, S. P., & Wiehler, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4637 · Cited by 154 · cited 1×
“Primary human bronchial epithelial (HBE) cells were prepared from normal human lung and were cultured in bronchial epithelial cell growth medium (BioWhittake, Walkersville, MD, USA) (Proud et al., 2004).”
MethodFKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92 · cited 5×
“This point is exemplified by the induction of FKBP51, which may act to dampen, or repress, the response to corticosteroids (Stechschulte and Sanchez, 2011).”
BackgroundInfluential
Cited by
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622
“However, FKBP5 induction can vary across individuals and has been proposed as a marker of GR sensitivity (Kelly et al, 2012; Menke et al, 2012; Vermeer et al, 2003).”
BackgroundGene–environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism
Zannas, A. S., & Binder, E. B. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12104 · Cited by 268
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
Clark, A. R., & Belvisi, M. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.004 · Cited by 209
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Metadata
- Authors
- Kelly, M., King, E., Rider, C., Gwozd, C., Holden, N., Eddleston, J., Zuraw, B., Leigh, R., O'Byrne, P., & Newton, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-02-22
- Volume
- 165
- Issue
- 6
- Pages
- 1737-1747
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1495764983
- Cited by
- 82
- References
- 6
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Corticosteroid‐induced gene expression in allergen‐challenged asthmatic subjects taking inhaled budesonide. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01620.x
- The paper
- Kelly, M., King, E., Rider, C., Gwozd, C., Holden, N., Eddleston, J., Zuraw, B., Leigh, R., O'Byrne, P., & Newton, R. (2012). Corticosteroid‐induced gene expression in allergen‐challenged asthmatic subjects taking inhaled budesonide. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01620.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.